Articles Tagged With:
-
Some Patients Request Ethics Consults — but for Issues Unrelated to Ethics
At Memorial Sloan Kettering Cancer Center, ethicists added a “Request Ethics Consultation” button to the electronic patient portal. However, of 74 ethics consult requests made through the portal, just one involved an ethics issue. All of the other requests fell outside the purview of the Ethics Consultation Service, such as people wanting help with hospital resources or care coordination.
-
Can Ethicists Be Sued for Recommendations? Attorneys Warn of Potential Legal Risks
The field of clinical ethics continues to evolve, with core competencies, certification, and documentation in the electronic medical record. In a recent paper, Claudia R. Sotomayor, MD, DBe, HEC-C, chief of the Ethics Consultation Service and a clinical ethicist at Georgetown University’s Pellegrino Center for Clinical Bioethics in Washington, DC, and colleagues explored whether the professionalization of ethics consultation exposes those working in this field to the types of liability claims faced by professionals in other fields.
-
Study Shows that Family Planning Needs of Hispanics Vary According to Acculturation
New research of Hispanic women surveyed at a public hospital in a New York City suburb shows that a large proportion — nearly three in five — were unaware of the Dobbs Supreme Court decision that overturned Roe v. Wade.
-
Study Suggests Need for Update in LARC Counseling About Acne
Investigators evaluated adolescent and young adult study participants seeking progestin-only long-acting reversible contraception (LARC) and found there was a risk of the contraceptive worsening acne.
-
Study: Small Decrease in Applicants to OB/GYN Residency Programs in Abortion-Ban States
Researchers looked at the impact of the overturn of Roe v. Wade on OB/GYN residency programs in the first year after the U.S. Supreme Court gave states the power to pass abortion bans with its decision in Dobbs v. Jackson Women’s Health Organization. They found there was a small but significant decrease in the number of applications to states with stricter abortion laws from 2022 to 2023.
-
What Did Supreme Court Justices Say About EMTALA and Abortion?
By the end of June, the U.S. Supreme Court will decide on whether Idaho and other states can require hospitals — through criminal laws — to turn away pregnant women experiencing a major health crisis when the best treatment for them is an abortion to end their pregnancy. Idaho presented a case that their state law preempts the Emergency Medical Treatment and Active Labor Act (EMTALA), and the federal government argued that EMTALA and the mission of protecting patients’ health and lives takes precedence.
-
EMTALA Has Protected Pregnant Patients for Three Decades — Now That Could Be at Risk
Health-preserving emergency care for pregnant women could be up to each physician’s conscience and risk-taking ability after the U.S. Supreme Court debates whether the state of Idaho is exempt from providing emergency abortion care to women who may lose their uteruses or kidneys or suffer other major health problems with delayed abortion care.
-
U.S. Supreme Court Unanimously Rejected Lawsuit Challenging FDA’s Mifepristone Decisions
Reproductive healthcare and abortion providers can exhale in relief — however briefly — because a unanimous U.S. Supreme Court decision maintains telehealth access to mifepristone, an abortion drug, in the United States.
-
Cardioversion in Obese Patients
A multicenter, single-blind, randomized clinical trial of dual vs. single defibrillator shocks for cardioverting obese patients with atrial fibrillation showed that dual defibrillation was significantly more effective without any increase in adverse events.
-
Are Women with Atrial Fibrillation Still at Higher Risk of Ischemic Stroke?
A Finnish national database study of newly diagnosed atrial fibrillation from 2007-2018 has shown that the independent association of ischemic stroke risk with female sex initially was high but trended downward to nonsignificant at the end of the study. This has implications for the risk stratification of atrial fibrillation patients regarding oral anticoagulation therapy.